|
|
|
Volumn 63, Issue 1, 2008, Pages
|
|
Ranolazine reduces HbA1c levels in patients with diabetes
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GLUCOSE;
HEMOGLOBIN A1C;
INSULIN;
PLACEBO;
RANOLAZINE;
AMINOTRANSFERASE;
CREATINE KINASE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
ROSUVASTATIN;
ACUTE CORONARY SYNDROME;
CLINICAL TRIAL;
DIABETES MELLITUS;
GLUCOSE BLOOD LEVEL;
HIGH RISK PATIENT;
HUMAN;
HYPERGLYCEMIA;
INCIDENCE;
MAJOR CLINICAL STUDY;
RECURRENCE RISK;
SHORT SURVEY;
ST SEGMENT ELEVATION;
AGED;
CARDIOVASCULAR DISEASE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE COURSE;
ELDERLY CARE;
FOLLOW UP;
OUTCOMES RESEARCH;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
RISK REDUCTION;
SWEDEN;
SYSTOLIC HEART FAILURE;
|
|
EID: 38549155098
PISSN: 0016867X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (2)
|
|
References (0)
|